Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2005
09/07/2005EP1569638A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1399434B1 Novel indole derivatives
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005EP1366039B1 Piperazinylcarbonylquinolines and -isoquinolines
09/07/2005EP1347957B1 Delta 1-pyrrolines used as pesticides
09/07/2005EP1289953B1 Serine protease inhibitors
09/07/2005EP1282621B1 Vitronectin receptor antagonists
09/07/2005EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1189893B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
09/07/2005EP1023308B1 Inhibitors of nucleoside metabolism
09/07/2005EP0888310B1 Cinnoline derivatives and use as medicine
09/07/2005CN1666577A Electronic devices made with electron transport and/or anti-quenching layers
09/07/2005CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions
09/07/2005CN1665823A Process for preparing 1, 2, 3, 9-tetrahydro-9-methyl-3-[2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
09/07/2005CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665816A Novel diketopyrrolopyrrole pigments
09/07/2005CN1665803A Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665791A Quinazoline derivatives
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665788A Pyrimidinone compounds, compositions and methods
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/06/2005US6939973 building block is a substituted amine radical
09/06/2005US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
09/06/2005US6939874 Substituted pyrimidinyl derivatives and methods of use
09/06/2005US6939869 Pyrrolo[2,1-c][1,4] benzodiazepine-indole derivatives, their preparation process, and uses of the same
09/06/2005US6939565 Protease inhibitors of the coagulation cascade isolated from Dysidea sponges
09/06/2005CA2127536C Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists
09/01/2005WO2005080394A1 4-substituted piperidine derivatives
09/01/2005WO2005080388A1 Viral polymerase inhibitors
09/01/2005WO2005080382A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
09/01/2005WO2005080381A1 New polymorphic forms of ondansetron, processes for preparing them, pharmaceutical compositions containing them and their use as antiemetics
09/01/2005WO2005080380A1 Kinase inhibitors
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080376A1 Substituted spiro azabicyclics as modulators of chemokine receptor activity
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080360A1 Compounds
09/01/2005WO2005080359A1 Benzamide derivatives and their use as glucokinae activating agents
09/01/2005WO2005080356A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
09/01/2005WO2005080354A1 1,2,4-triazines derivatives, preparation thereof and use thereof in human therapeutics
09/01/2005WO2005080346A1 Substituted azole derivatives, compositions, and methods of use
09/01/2005WO2005080335A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
09/01/2005WO2005080331A1 Fluorescent probe
09/01/2005WO2005080318A1 PROCESSES FOR PRODUCTION OF α-AMINOOXYKETONES AND α-HYDROXYKETONES
09/01/2005WO2005079802A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005WO2005079799A1 4-acyl-piperazines as anti-viral agents
09/01/2005WO2005079798A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005WO2005079574A1 Bicyclic melanocorin-specific compounds
09/01/2005WO2005079496A2 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005US20050192339 Compounds
09/01/2005US20050192335 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
09/01/2005US20050192331 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/01/2005US20050192330 Using 4-imidazoline carboxylic acid or ester; antiinflammatory agents; microbiocides; bactericides; antitumor agenst0
09/01/2005US20050192304 Rho-kinase inhibitors
09/01/2005US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity
09/01/2005US20050192294 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
09/01/2005US20050192293 Vanilloid receptor VR1 modulators; pain, inflammation, traumatic injury, autoimmune disease; compounds are pyridine subsituted at 2 position with an amido-, sulfoamido- or thioamide-substituted (N-hetero)aryl ring
09/01/2005US20050192292 Pyrrolidone carboxamides
09/01/2005US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto
09/01/2005US20050192279 Pyridazinones as antagonists of alpha4 integrins
09/01/2005US20050192269 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
09/01/2005US20050192268 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
09/01/2005US20050190182 Data-driven layout engine
09/01/2005DE10247680B4 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase New bicyclic inhibitors of hormone sensitive lipase
09/01/2005CA2556589A1 4-substituted piperidine derivatives
09/01/2005CA2556480A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005CA2556263A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2555812A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
09/01/2005CA2555402A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005CA2555071A1 Histamine-3 receptor modulators
09/01/2005CA2554774A1 Novel heterocyclic compound
09/01/2005CA2554686A1 Compounds
09/01/2005CA2554310A1 Benzamide derivatives and their use as glucokinase activating agents
09/01/2005CA2498966A1 Novel pyrazole analogs acting on cannabinoid receptors
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567518A2 Oxime ester photoinitiators with heteroaromatic groups
08/31/2005EP1567517A1 Anilinopyrazole derivatives useful for the treatment of diabetes
08/31/2005EP1567507A1 1,2,3- triazole amide derivatives as cytokine inhibitors
08/31/2005EP1567506A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
08/31/2005EP1567503A1 Pyrazole derivatives useful as cox-i inhibitors
08/31/2005EP1567494A1 Methods for preparing phenylalkyne derivatives
08/31/2005EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
08/31/2005EP1567010A1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1237875B1 Substituted imidazole neuropeptide y y5 receptor antagonists
08/31/2005EP1156047B1 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662234A Use of thio-oxindole derivatives in treatment of hormone-related conditions
08/31/2005CN1662206A Use of thio-2-oxindole derivatives in treatment of skin disorders
08/31/2005CN1660821A Oxodiethylenediamine derivative and light stabilized composition
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/30/2005US6936626 Retinoic acid mimetic anilides
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 626